Advertisement
UK markets open in 5 hours 14 minutes
  • NIKKEI 225

    37,912.06
    -548.02 (-1.42%)
     
  • HANG SENG

    17,156.47
    -44.80 (-0.26%)
     
  • CRUDE OIL

    82.67
    -0.14 (-0.17%)
     
  • GOLD FUTURES

    2,330.00
    -8.40 (-0.36%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,621.30
    -2,033.14 (-3.79%)
     
  • CMC Crypto 200

    1,395.13
    -28.97 (-2.04%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

What Falling Estimates & Price Mean for Endo International (ENDP)

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio.

One such stock that you may want to consider dropping is Endo International plc ENDP, which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. A Zacks Rank #5 (Strong Sell) further confirms weakness in ENDP.

A key reason for this move has been the negative trend in earnings estimate revisions. For the full year, we have seen four estimates moving down in the past 30 days, compared with no upward revisions. This trend has caused the consensus estimate to trend lower, going from $2.43 a share a month ago to its current level of $2.33.

Also, for the current quarter, Endo International has seen one downward estimate revisions versus no revisions in the opposite direction, dragging the consensus estimate down to 54 cents a share from 56 cents over the past 30 days.  

ADVERTISEMENT

The stock also has seen some pretty dismal trading lately, as the share price has dropped 9% in the past month.

Endo International plc Price and Consensus

Endo International plc Price and Consensus | Endo International plc Quote

 

So it may not be a good decision to keep this stock in your portfolio anymore, at least if you don’t have a long time horizon to wait.

If you are still interested in the Medical - Drugs industry, you may instead consider a better-ranked stock - Eisai Co., Ltd. ESALY. The stock currently holds a Zacks Rank #1 (Strong Buy) and may be a better selection at this time. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Endo International plc (ENDP) : Free Stock Analysis Report
 
Eisai Co. (ESALY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research